Operator

Hello, and welcome. You are joining Knight Therapeutics Annual General Meeting. Please note that today's meeting is being recorded. [Operator Instructions]

I would now like to turn today's meeting over to Jonathan Goodman, Chairman of the meeting.

Jonathan Goodman
Executive Chairman

Good morning, ladies and gentlemen. Welcome to Knight Therapeutics' Annual Meeting of Shareholders. Once again, this year, we have chosen to hold the meeting via live audio webcast. My name is Jonathan Goodman, Executive Chair of Knight Therapeutics, and I will chair today's meeting.

Also with me on the call is Samira Sakhia, our President and Chief Executive Officer; and [ Emily O'Donohue ], our external counsel. Samira will act as Secretary of today's meeting. [ Charles Musseleem ] and [ Elion Diang ] of Computershare Investor Services will be acting as scrutineers for this meeting.

We believe that this format encourages broader participation from shareholders regardless of their geographic location and provides all shareholders with an equal opportunity to engage in the meeting. We remain committed to encouraging and promoting shareholder participation and facilitating the exercise by all shareholders of their rights to vote, attend and participate in the meeting.

Our agenda today is straightforward. First, we will conduct the formal part of the meeting. Following the formal part of the meeting, Samira will make a few remarks. Finally, we will do our best to answer any questions you may have. Questions, objections, proposals and comments may be provided by registered shareholders or their duly appointed proxy holders through the question box identified by the message icon on the top right portion of your screen. To respond, our external counsel will read the questions aloud, and either I or Samira will respond. Please